Regularly consuming aspirin has been associated with a decreased chance of developing pancreatic cancer, says a new study.
Researchers collected data from over 1,000 people for the study, some with pancreatic cancer and somewhat without. What they found was that taking low-does aspirin could lower the risk of developing the cancer by up to 60 percent. Meanwhile, taking regular aspirin could reduce the risk by a whopping 73 percent.
The researchers are not entirely sure why aspirin lowers the risk so greatly, but were not necessarily surprised by the information. Other forms of cancer have lowered development risk when taking aspirin. That includes lung, stomach, ovarian, and breast cancer.
For people that are at high risk for developing pancreatic cancer, taking aspirin regularly can be a positive thing. However, it is always best to consult a doctor first, as aspirin can have adverse side effects.
Pancreatic cancer is one of the most deadliest forms of cancer, with only around 6.7 percent of patients surviving more than five years after being diagnosed. The cancer is expected to claim around 40,000 lives by the end of the year.
The study was published online in Cancer Epidemiology, Biomarkers and Prevention.